Charles River Laboratories | CRL - Ativo Circulante





Ativo Circulante Alterar Data
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 7.62M 2026-06
Bio-Rad Laboratories USD 3.02B 78.4M 2026-06
Bruker USD 2.22B 121.4M 2026-06
Cardinal Health USD 38.75B 689M 2026-06
Charles River Laboratories USD 1.53B 40.3M 2026-06
Cigna USD 46.99B 3.96B 2026-06
Concord Medical Services Hldg CNY 941.91M 83.42M 2025-12
CVS Health USD 75.35B 529M 2026-06
Danaher USD 13.38B 554M 2026-06
Dentsply International USD 1.93B 83M 2026-06
Elevance Health USD 67.18B 152M 2026-06
Humana USD 38.08B 5.35B 2026-03
Illumina USD 2.83B 96M 2026-06
Incyte USD 6.03B 542.31M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
IQVIA Holdings USD 6.23B 6M 2026-06
Laboratory Of America USD 3.81B 743.9M 2026-06
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Lonza CHF 8B 3.41B 2025-12
McKesson USD 62.84B 5.63B 2026-06
Merck EUR 13.77B 393M 2026-06
Mettler Toledo International USD 1.35B 15.48M 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Quest Diagnostics USD 2.84B 278M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06
UnitedHealth USD 86.86B 4.27B 2026-06
Veradigm USD 679.65M 131.12M 2022-12
Waters USD 3.9B 186M 2026-06
West Pharmaceutical Services USD 1.81B 19.3M 2026-06